Safety of synchronous prophylactic ablation of the anterior saphenous vein in patients undergoing great saphenous vein thermal ablation- 6 months follow-up data of the SYNCHRONOUS study

Background - The SYNCHRONOUS-study investigates simultaneous ASV-ablation with great saphenous vein (GSV) treatment in endovenous laser ablation (EVLA) for preventing varicose vein recurrence. This sub-study examines complication rates associated with prophylactic ASV-ablation. - Methods - Among 117...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Dietrich, Carmen (VerfasserIn) , Hirsch, Tobias (VerfasserIn) , Hartmann, Karsten (VerfasserIn) , Mattausch, Thomas (VerfasserIn) , Wenzel, Hans-Christian (VerfasserIn) , Zollmann, Philipp (VerfasserIn) , Veltman, Jürgen (VerfasserIn) , Weiler, Thomas K (VerfasserIn) , Lengfellner, Guido (VerfasserIn) , Müller, Lars (VerfasserIn) , Stücker, Markus (VerfasserIn) , Pannier, Felizitas (VerfasserIn) , Uhlmann, Lorenz (VerfasserIn) , Müller-Christmann, Christine (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2024
In: Phlebology
Year: 2024, Jahrgang: 39, Heft: 9, Pages: 585-591
ISSN:1758-1125
DOI:10.1177/02683555241257840
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1177/02683555241257840
Volltext
Verfasserangaben:Carmen K Dietrich, Tobias Hirsch, Karsten Hartmann, Thomas Mattausch, Hans-Christian Wenzel, Philipp Zollmann, Jürgen Veltman, Thomas K Weiler, Guido Lengfellner, Lars Müller, Markus Stücker, Felizitas Pannier, Lorenz Uhlmann, Christine Müller-Christmann
Beschreibung
Zusammenfassung:Background - The SYNCHRONOUS-study investigates simultaneous ASV-ablation with great saphenous vein (GSV) treatment in endovenous laser ablation (EVLA) for preventing varicose vein recurrence. This sub-study examines complication rates associated with prophylactic ASV-ablation. - Methods - Among 1173 patients with refluxing GSV, 604 underwent GSV-ablation only, and 569 received additional ASV-ablation. Complication rates were compared over 6 months. - Results - Approximately 80% of patients were complication-free with minor bruising and dysesthesia being most common complications. After 6 months, additional prophylactic ASV-ablation did not increase the rate of complications compared to GSV-only treatment. - Conclusion - The 6-months follow-up data suggests that prophylactic ASV-closure, alongside GSV-treatment, is safe, with similar complication rates to GSV-only EVLA.
Beschreibung:Online veröffentlicht: 30. Mai 2024
Gesehen am 21.01.2025
Beschreibung:Online Resource
ISSN:1758-1125
DOI:10.1177/02683555241257840